GINN - ETF AI Analysis
Top Page
Goldman Sachs ETF Trust Goldman Sachs Innovate Equity ETF (GINN)
GINN vs. SPDR S&P 500 ETF (SPY)
- AUM
- 178.71M
- Region
- Global
- Expense Ratio
- 0.50%
- Beta
- 1.09
- Issuer
- Goldman Sachs
- Inception Date
- Nov 06, 2020
- Dividend Yield
- 1.14%
- Asset Class
- Equity
- Index Tracked
- Solactive Innovative Global Equity Index
GINN Summary
GINN is the Goldman Sachs Innovate Equity ETF, built to follow the Solactive Innovative Global Equity Index and focus on companies driving new ideas and technologies. It mainly holds U.S. stocks across tech, healthcare, and consumer sectors, including well-known names like Apple and Microsoft. Investors might consider GINN if they want growth potential from innovative businesses and a diversified mix of global companies rather than a single stock. However, because it leans heavily toward fast-changing industries like technology and healthcare, its price can go up and down more sharply than the overall market.
How much will it cost me?
This ETF has an expense ratio of 0.50%, which means you’ll pay about $5 per year for every $1,000 invested. That’s higher than the average low-cost index ETF because it’s a more specialized, thematically focused fund that requires more active research and management to select innovative companies.
What would affect this ETF?
GINN could benefit if global economic growth stays solid and innovation-focused sectors like technology and healthcare continue to thrive, especially since its top holdings include major tech and biotech leaders such as Apple, Microsoft, Nvidia, and Eli Lilly. On the negative side, higher interest rates, tighter regulations on big tech or healthcare, or a downturn in consumer and financial markets could hurt these innovative companies and weigh on the ETF’s performance, particularly given its global exposure to market and policy changes.
GINN Top 10 Holdings
GINN is riding the Big Tech and AI wave, with Apple and Nvidia doing much of the heavy lifting as their shares keep climbing on the back of strong demand for devices, chips, and AI infrastructure. Meta has turned into a surprise engine of growth, adding extra fuel with its recent rally. On the flip side, Amazon looks a bit tired, and Tesla is clearly dragging the fund, with both showing weaker momentum. While Eli Lilly adds a steady healthcare angle, the story here is a globally focused, innovation-heavy portfolio dominated by U.S. tech leaders.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 AAPL | Apple | 2.27% | $4.05M | $5.09T | 29.37% | 79Outperform |
 MSFT | Microsoft | 2.16% | $3.86M | $3.94T | -2.11% | 79Outperform |
 NVDA | Nvidia | 1.95% | $3.47M | $5.15T | 3.20% | 76Outperform |
 AMZN | Amazon | 1.81% | $3.23M | $2.63T | 5.86% | 71Outperform |
 GOOGL | Alphabet Class A | 1.64% | $2.91M | $3.46T | 3.37% | 85Outperform |
 META | Meta Platforms | 1.70% | $3.03M | $1.60T | -16.92% | 76Outperform |
 TSLA | Tesla | 1.36% | $2.42M | $1.59T | -12.61% | 73Outperform |
 INTC | Intel | 1.19% | $2.11M | $486.69B | 122.71% | 64Neutral |
 LLY | Eli Lilly & Co | 1.12% | $2.00M | $1.29T | 68.86% | 72Outperform |
 HK:0700 | Tencent Holdings | 0.99% | $1.76M | HKD 3.40T | -41.46% | 75Outperform |
GINN Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GINN, the sentiment is Positive. The current price of 81.02 is above the 20-day moving average (MA) of 80.95, below the 50-day MA of 81.43, and above the 200-day MA of 76.99, indicating a neutral trend. The MACD of -0.19 indicates Negative momentum. The RSI at 50.50 is Neutral, neither overbought nor oversold. The STOCH value of 77.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GINN.
GINN Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| GINN | $81.02 | $88.00(8.61% Upside) | $178.71M | 0.50% | 69Neutral |
 ILDR | $37.72 | $54.54(44.59% Upside) | $358.33M | 0.75% | 67Neutral |
 TMAT | $28.64 | $40.15(40.19% Upside) | $255.28M | 0.79% | 68Neutral |
 YNOT | $31.46 | $40.87(29.93% Upside) | $212.17M | 0.75% | 61Neutral |
 SPRX | $40.29 | $67.47(67.46% Upside) | $197.74M | 0.75% | 65Neutral |
 NBDS | $40.22 | $56.36(40.12% Upside) | $178.46M | 0.40% | 67Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GINN | Goldman Sachs ETF Trust Goldman Sachs Innovate Equity ETF | 81.02 | 6.24 | 8.34% | |
| ILDR | First Trust Innovation Leaders ETF | 37.72 | 3.26 | 9.47% | |
| TMAT | Main Thematic Innovation ETF | 28.64 | 0.31 | 1.08% | |
| YNOT | Horizon Digital Frontier ETF | 31.46 | 1.39 | 4.62% | |
| SPRX | Spear Alpha ETF | 40.29 | -3.23 | -7.43% | |
| NBDS | Neuberger Berman Disrupters ETF | 40.22 | 1.65 | 4.28% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.